Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
32 /100
COMPONENT-LIMITED
Score updated Aug 28, 2026

IRWD — Ironwood Pharmaceuticals, Inc. Dilution Risk Tracker

Track IRWD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IRWD — Get alerts when the score changes →

As of August 28, 2026, Ironwood Pharmaceuticals, Inc. (IRWD) has a DilutionWatch DilutionScore of 32/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Ironwood Pharmaceuticals, Inc. has a market capitalization of $587.67M, 165.24M shares outstanding, 227 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰Cash Runway
📊 Float Risk
22
⚠️ Warrant Exposure
40
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 34%
🔁 Convertible Conversion model 60%
• Major convertible overhang: 68% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split model est. 15%
• 52-week low $0.56 has breached $1
🔔 Track IRWD — Get forecast alerts →

Market Data

Market Cap$587.67M
Shares Outstanding165.24M
Float136.34M
Cash$79.13M
Debt$320.21M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 6.7% shares (2026Q1 vs prior)
227 institutional holders · 190.05M shares
#1 ARMISTICE CAPITAL, LLC 15.03M shares
#2 BlackRock, Inc. 13.36M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 12.19M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest16.54M
Days to Cover10.0
% of Float12.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2023-12-31
xbrl XBRL CONVERTIBLE 2019-12-31
4 INSIDER TRANSACTION 2026-03-17
4 INSIDER TRANSACTION 2026-03-12
4 INSIDER TRANSACTION 2026-03-12
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IRWD Dilution Snapshot

Ironwood Pharmaceuticals, Inc. (IRWD) has a DilutionScore of 32/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IRWD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IRWD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for IRWD
IRWD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.